baber/WOPTO huggingface dataset:
Patent NZ-552076-A (NZ)
Title: Improved synthesis scheme for lacosamide
Inventor: RIEDNER JENS
IPC: C07C231/02
Filed: 2005-09-30
Abstract: Disclosed is a method of producing (R)-2-acetamido-N-benzyl-3-methoxypropionamide (Iacosamide) comprising the O-methylation of a compound of formula I to produce a compound of formula II wherein Rx is an N-protecting group, and wherein the compound of formula II is reacted with benzylamine to give the compound of formula III, and the protecting group Rx is replaced with methyl carbonyl to give (R)-2- acetamido-N-benzyl-3-methoxypropionamide,characterised in that the O-methylation is being carried out in a one-step reaction and wherein the compound of formula II is obtained as an R-enantiomer of at least 88% purity and the method is performed either (a) as a phase transfer catalysis or (b) by adding a methylation agent and an organo lithium compound to the compound of formula I.
Patent NZ-553226-A (NZ)
Title: Protected vial, and method for manufacturing same
Inventor: DE VOS DICK
IPC: A61J1/00
Filed: 2005-08-17
Abstract: Disclosed is a protected vial and its method of manufacture. The vial includes a tight-fitting outer envelope (6) which conforms to the shape of the vial. The envelope (6) includes a bottom sticker (602) which is attached to the bottom (202) of the vial (2) and a tight-fitting sleeve (601), which is shrunken onto the side wall (201) of the vial (2), while partly overlapping the bottom sticker (602) along a circumferential edge of the bottom (202). As a result of the arrangement of the envelope (6), any spillage or contamination which occurs during filling and remains on the outside of the vial (2) is encapsulated between the vial (2) and the envelope (6). Consequently, a user is no longer exposed to toxic substances, because the user will not touch the vial (2) itself, but will touch the envelope (6).
Patent NZ-556735-A (NZ)
Title: Securing devices and equipotential bonding system
Inventor: STOJADINOVIC GORAN
Filed: 2007-07-24
Abstract: A system for creating an equipotential along a pole comprises: a conductive downlead for fixing to and extending substantially along the length of the pole to electrically connect to the pole substantially along the length of the conductive downlead or at least at intervals along the length of the conductive downlead sufficient to create an equipotential along the pole; and a liquid distribution system for supplying a liquid between the conductive downlead and the pole.
Patent NZ-563737-A (NZ)
Title: Amylases derived from Bacillus stearothermophilus optionally in combination with proteases and/or lipases for pharmaceutical use
Inventor: SVENDSEN ALLAN
IPC: A61K38/47
Filed: 2006-06-16
Abstract: The pharmaceutical use of amylases having at least 70% sequence identity to amino acids 1-481 of SEQ ID NO: 1, the amylase derived from Bacillus stearothermophilus, optionally in combination with a protease and/or lipase for treatment of pancreatic exocrine insufficiency.
Patent NZ-565054-A (NZ)
Title: Pharmaceutical formulations of endo-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride (granisetron) comprising a preservative of alkyl paraben and an acetate buffer
Inventor: SINGH KIRAN PAL
IPC: A61K9/08
Filed: 2006-06-19
Abstract: Disclosed is a pharmaceutical formulation suitable for multi-dose administration comprising endo-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1H-indazole-3-carboxanide hydrochloride, a preservative selected from the group consisting of alkyl paraben and phenol, and a buffer selected from the group consisting of acetate and phosphate buffers.
Patent NZ-566879-A (NZ)
Title: Acaricidal compositions comprising an omega-ACTX peptide
Inventor: KING GLENN F
IPC: A01N63/50
Filed: 2006-09-13
Abstract: Disclosed is a method of controlling acarine pests, comprising applying an effective amount of an isolated polypeptide, or a composition comprising an isolated polypeptide to a locus of the acarine pests. The disclosed polypeptide is an omega-ACTX peptide having greater than or equal to 70% sequence identity to SEQ ID NO: 1; capable of forming three intrachain disulfide bonds; and having six conserved cysteine residues at positions corresponding to amino acid positions 4, 11, 17, 18, 22 and 36 of SEQ ID NO: 1, and wherein said locus is not a locus on or in the body of a human.
Patent NZ-572107-A (NZ)
Title: VEGF traps and therapeutic uses thereof
Inventor: DALY THOMAS J
IPC: A61K38/00
Filed: 2004-06-29
Abstract: Provided is an isolated nucleic acid molecule encoding a fusion polypeptide comprising components (R1R2)x, wherein R1 is vascular endothelial cell growth factor (VEGF) receptor component Ig domain 2 of Flt-1 consisting of amino acids 27 to 126 of SEQ ID No: 8 or amino acids 27 to 129 of SEQ ID No: 10, and R2 is Ig domain 3 ofFlk-1 consisting of amino acids 127 to 228 of SEQ ID No: 8 or amino acids 130 to 231 of SEQ ill No: 10, and wherein X = 2. Further provided is the use of the composition in the manufacture of a medicament for treating various diseases related to undesirable plasma leakage.
Patent NZ-576850-A (NZ)
Title: Method and motor for generating rotation about an output axis
Inventor: OZTURK MUSTAFA NACI
IPC: G01C19/00
Filed: 2006-11-13
Abstract: A rotary motor which can supply output motive power about an output axis in response to input rotary power about a different axis. A motor (1) comprises a wheel (2) mounted on a shaft (3) for rotation about a first axis (4). The shaft is additionally mounted for rotation about both an inclination axis and the output axis (11) of the motor.
Patent NZ-578369-A (NZ)
Title: Ridged serpentine microwave waveguide applicator
Inventor: HALLAC ABDULKADIR
IPC: H05B6/78
Filed: 2008-01-24
Abstract: Disclosed is a microwave applicator which includes a serpentine waveguide having a first end and a second end and an applicator portion between the first and second ends. The waveguide includes a number of waveguide passes arranged with opposite top and bottom sides which are connected to a pair of opposite slotted sides having slots between the top and bottom sides so as to form a generally rectangular interior cross section. The waveguide passes are disposed side by side with the slots aligned. The microwave applicator also includes a microwave energy source coupled to the first end of the serpentine waveguide to supply microwave energy flowing through the serpentine waveguide to the second end. The waveguide has bent end portions connecting adjacent waveguide passes in series so that microwave energy flows in an opposite direction in each adjacent waveguide pass. The microwave applicator includes a conveyor extending through the aligned slots in the applicator portion to transport a material into the applicator portion for exposure to microwave energy. The microwave applicator further includes tunnels disposed between facing slotted sides of consecutive waveguide passes to enclose the material transported by the conveyor between the waveguide passes. The waveguide passes have conductive ridges projecting interiorly from corners of the waveguide passes to reduce the microwave energy at the slots in the slotted sides of the waveguide passes.
Patent NZ-579116-A (NZ)
Title: Stator arrangement, generator, wind turbine, and method for positioning a stator arrangement
Inventor: STIESDAL HENRIK
IPC: F03D1/02
Filed: 2009-08-18
Abstract: A stator arrangement, a generator having the stator arrangement, a wind turbine having a generator with the stator arrangement, and a method of positioning a stator is disclosed. The stator arrangement of the electric machine is set up in a cylindrical form where the stator arrangement is radially surrounded by a rotatably mounted rotor arrangement. During normal operation the stator arrangement is non-rotatably connected to a stationary part of the electric machine. The stator arrangement is releasable from the non-rotatable connection to the stationary part of the electric machine where the stator arrangement is interlockable with a rotating part of the electric machine causing the stator arrangement to revolve if the rotating part rotates.
Patent NZ-579405-A (NZ)
Title: An bolt assembly adjustable in length to between a short or long backset mode
Inventor: CONSTANTINOU JOHN
IPC: E05B63/06
Filed: 2009-09-02
Abstract: An adjustable bolt assembly is disclosed. The bolt assembly forms part of a cylindrical lock set by connection to a cylindrical lock assembly such that the backset of the bolt assembly can be easily adjusted. The cylindrical lock assembly includes a chassis housing a shuttle with the cylindrical lock assembly being operable to move the shuttle relative to the chassis so as to move a lock bolt of the bolt assembly between an operative position and an inoperative position. The bolt assembly can be operated in a short backset mode or a long backset mode. The bolt assembly includes a housing (11), a lock bolt, a draw bar (15) and a tail bar (8) associated with the draw bar (15) which has a tail end connected to the shuttle. The lock bolt is movable relative to the housing between an extended operating position and a retracted non-operating position. The draw bar (15) has a head end connected to the bolt. A detent (17) is biased towards connecting the tail bar (8) and the draw bar (15) so that they operate together in normal use. When the detent (17) is moved out of engagement, the tail bar (8) is movable in an axial direction relative to the draw bar (15) so as to adjust the operation of the bolt assembly between the short backset mode and the long backset mode. A conversion tool (23) may be used to facilitate the change in mode.
Patent NZ-585998-A (NZ)
Title: Electric switch unit
Inventor: MARSH BENJAMIN KEITH
IPC: H01H9/04
Filed: 2008-11-12
Abstract: Disclosed is a switch unit for use with a face plate. The switch unit has a seal connected thereto to facilitate the installation of the switch unit, as well as subsequent reorientation of the switch unit with respect to the face plate. In one form, the seal is connected to a top surface of a dolly housing of the switch unit. Also disclosed is a frame for removably retaining the switch unit to the face plate.
Patent NZ-593812-A (NZ)
Title: Glucagon analogues
Inventor: MEIER EDDI
IPC: A61K38/26
Filed: 2008-12-15
Abstract: 593810 Discloses a compound having the formula R1-X-Z-R2 wherein the peptide has the formula HIS-SER-GLN-GLY-THR-PHE-THR-SER-ASP-THY-SER-LYS-TYR-LEU-ASP-SER-LYS-ALA-ALA-HIS-ASP-PHE-VAL-GLU-TRP-LEU-ARG-ALA and variations thereof. Also describes the use of the compound in preventing weight gain, promoting weight loss.
Patent NZ-595899-A (NZ)
Title: Logical and physical security
Inventor: HERNOUD MELANI S
IPC: G06F21/00
Filed: 2007-04-25
Abstract: A method for operating a converged physical and logical security management system and a converged physical and logical security management system are disclosed. The converged physical and logical security management system comprises either: a) a unique identifier having associated therewith information usable for authentication and authorization to control access decisions for a physical area and logical access to one or more of a computer system, computer network or network resource with the information including at least two configuration options; and a security management computer including at least one microprocessor, a data store and connectivity modules or b) circuitry for providing a unique identifier having associated therewith information usable for authentication and authorization to control access decisions for a physical area and logical access to one or more of a computer system, computer network or network resource, the information including at least two configuration options; and means for operating a security management system run on a computer managing a security management computer that includes at least one microprocessor, a data store and connectivity modules. The security management computer is scalable via one or more connections to one or more additional security management computers and the security management computer determines the access decisions for the physical area and the logical access to the one or more of the computer system, the computer network or the network resource. The security management computer connects to one or more access control readers and capable of communicating with the one or more access control readers in the access control readers' standard protocol. The security management computer also includes a directory service that is used with the data store and the configuration options to make the access decisions. For an access request to the physical area, a first authentication and authorization utilize a first of the at least two configuration options within the data store of the security management computer for a physical access decision, and for logical access, a second, separate, authentication and authorization utilize a second of the at least two configuration options within the directory service of the security management computer for a logical access decision.
Patent NZ-596234-A (NZ)
Title: A method for improving egg quality using blackcurrant and/or boysenberry extract
Inventor: KANO YASUHIRO
IPC: A23L19/00
Filed: 2010-05-31
Abstract: Patent No. 596234 Disclosed is a method for improving or supporting egg quality and/or productive egg laying life span, preventing deterioration in egg shell integrity, enhancing egg-laying performance, egg quality and colour, egg white and yolk texture, nutritional value and/or odour, and/or increasing polyphenol content in an egg in a bird, the method comprising administering to the bird black currants or a composition comprising one or more of processed whole blackcurrants, processed whole boysenberries, one or more natural component extracted from blackcurrants, and/or one or more natural component extracted from boysenberries.
Patent NZ-598938-A (NZ)
Title: Method and internet protocol short message gateway (ip-sm-gw) for providing an interworking service between converged ip messaging (cpm) and short message service (sms)
Inventor: GREENE NANCY M
IPC: H04L12/58
Filed: 2010-10-05
Abstract: A method for providing an interworking service between Converged IP Messaging and Short Message Service, by an Internet Protocol Short Message Gateway and the Internet Protocol Short Message Gateway are disclosed. The Internet Protocol Short Message Gateway comprises a receiving interface, a processor and a sending interface. The receiving interface receives a chat session invitation. The chat session invitation originates from a Converged IP Messaging User Equipment and is sent toward a Short Message Service enabled user equipment. The receiving interface receives from the Converged IP Messaging User Equipment a message containing data within the chat session. The message contains data is sent to the Short Message Service enabled user equipment. The processor assigns a Mobile Station international Subscriber Directory Number to the chat session and formats the message containing data into a Short Message Service Message. The Mobile Station international Subscriber Directory Number assigned to the chat session is inserted as a sender of the Short Message Service message to ensure that a Short Message Service response is sent back to Internet Protocol Short Message Gateway. The sending interface sends an invitation acknowledgement from Internet Protocol Short Message Gateway to the Converged IP Messaging User Equipment and forwards the formatted Short Message Service message to Short Message Service enabled user equipment.
Patent NZ-599084-A (NZ)
Title: Circulating fluidized bed with in-furnace nozzles extending from the top of bubbling fluidized bed until the outer wall
Inventor: MARYAMCHIK MIKHAIL
IPC: B01J8/18
Filed: 2010-09-28
Abstract: 599084 Disclosed is a circulating fluidized bed (CFB) boiler with a CFB reaction chamber having side walls and a grid defining a floor at a lower end of the CFB reaction chamber. The boiler has a bubbling fluidized bed (BFB) located within a lower portion of the CFB reaction chamber. The BFB is bound by outer wall(s) of the CFB reaction chamber, the floor of the CFB reaction chamber and enclosure wall(s) formed by cooled tubes that extend upward from the floor of the CFB to the height of the BFB. The boiler has a controllable in-bed heat exchanger (IBHX) which has a heating surface and occupies part of part of the CFB reaction chamber floor. The INHX is surrounded by the enclosure walls of the BFB. The boiler has an in-furnace secondary air nozzle formed by the cooled tubes of the BFB enclosure wall that are formed into at least one group that extends from the top of the BFB enclosure wall across the width of the BFB until reaching the outer wall of the CFB.
Patent NZ-600517-A (NZ)
Title: Respiratory mask
Inventor: VELISS LEE JAMES
IPC: A61M16/06
Filed: 2008-02-29
Abstract: A connection portion (100) of a respiratory mask (12) for receiving an air delivery tube is disclosed. The connection portion comprises a relatively thin-walled flexible portion (96) configured to sealingly receive the air delivery tube in aperture (90). A relatively rigid portion (98) surrounds the relatively thin-walled portion (96). The relatively thin walled portion (96) is configured to flex, move or bend towards the front of the mask so that when the air delivery tube is inserted into the aperture (90) a seal is formed and the mask (12) is substantially decoupled from movement of the tube.
Patent NZ-601700-A (NZ)
Title: 5-phenyl-1H-pyridin-2-one and 6-phenyl-2H-pyridazin-3-one derivatives as inhibitors of Bruton's Tyrosine Kinase (Btk)
Inventor: DEWDNEY NOLAN JAMES
IPC: C07D417/14
Filed: 2009-06-15
Abstract: ABSTRACT - 601700 Discloses herein are 5-phenyl-1H-pyridin-2-one and 6-phenyl-2H-pyridazin-3-one derivatives according to generic formulae (I) & (II), wherein variables R, X, Y1, Y2, Y2', Y3, Y4, n and m are as defined in the specification. These compounds inhibit Bruton's Tyrosine Kinase (Btk) and are useful for the treatment of diseases caused by aberrant B-cell activation. The compounds disclosed herein are useful to modulate the activity of Btk and treat diseases associated with excessive Btk activity. These compounds are further useful to treat inflammatory and auto immune diseases associated with aberrant B-cell proliferation such as rheumatoid arthritis. Also disclosed are compositions comprising compounds of formulae (I) & (II) and at least one carrier, diluent or excipient.
Patent NZ-607590-A (NZ)
Title: Process of producing shelf stable probiotic food
Inventor: NAG ARUP
IPC: A23L33/00
Filed: 2011-08-25
Abstract: Discloses a process for preparing consumable coated particles comprising coating particles comprising carbohydrate and protein with a suspension of osmotically shocked probiotic microorganisms and drying the coated particles. It further discloses consumable particles comprising carbohydrate, protein and optionally fat with a suspension of osmotically shocked probiotic microorganisms and drying the coated particles.
Patent NZ-615885-A (NZ)
Title: High velocity mist evaporation
Inventor: ATTEY GRAEME SCOTT
IPC: F28C3/08
Filed: 2012-03-21
Abstract: An evaporation system (10) and method has at least one fan (9) operatively connected to drive means to effect fan rotation, at least one flow path to supply liquid to at least one nozzle (12) to spray a mist of the liquid under centrifugal pressure. Velocity differential between the rotating nozzle(s) and airflow created by the at least one fan provides evaporation of the sprayed liquid. Inlet vanes (60) direct airflow in a direction contra to fan rotation to increase velocity differential. The nozzles can be on fan blades (4) and/or a central disc/hub. The method and system can be used for air conditioning, snow making, desalination or in industrial or commercial evaporators.
Patent NZ-618364-A (NZ)
Title: Resealable pouch assembly for containing liquid
Inventor: DARCY MARK LUCAS
IPC: B65D75/58
Filed: 2012-12-10
Abstract: 618364 A resealable pouch assembly has a pouch formed by seals and has a straw inserted which can be moved from a stowed bent position within a chamber adjacent to the pouch, to a drinking position outside of the chamber. In another embodiment the chamber has a zipper type seal above the straw so as to seal off the chamber.
Patent NZ-623782-A (NZ)
Title: Plant for cleaning a freight container
Inventor: GRAHAM STANLEY REIHER
IPC: B65D88/12
Filed: 2014-04-11
Abstract: A plant (1) for the internal cleaning and drying of an ISO freight container (7) is disclosed. The plant includes a) support means (8) adapted for receiving and supporting an ISO freight container; b) a cleaning module (4); c) an arrangement of track (5); and d) sensing means. The plant is arranged such that an ISO freight container can be supported by the support means so that the cleaning module is able to move automatically along the track and, guided by the sensing means, position itself within the container and apply fluid to the interior of the container to clean it. The cleaning module has fluid nozzles, brushes and air blowers for drying the container. Multiple containers may be processed by the plant. Cleaning fluids are recycled.
Patent NZ-629442-A (NZ)
Title: Heterocyclyl compounds as mek inhibitors
Inventor: DAVE BHAVESH
IPC: C07D471/04
Filed: 2013-03-11
Abstract: Disclosed herein are pyridyo-pyrimidine-trione compounds represented by formula I where the substituents are as defined herein. Also disclosed are tautomers and pharmaceutically acceptable salts, combinations with suitable medicament and pharmaceutical compositions thereof. The compounds are inhibitors of MEK and are therefore intended for use in the treatment of diseases including cancer. Also disclosed are processes of preparation of the compounds. Examples of the compounds of formula I include 1-(3-(cyclopropylsulfonyl)phenyl)-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethylpyrido[4,3-d]pyrimidine-2,4,7(1H,3H,6H)-trione and N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)-3-methyloxetane-3-carboxamide.
Patent NZ-711225-A (NZ)
Title: A pharmaceutical formulation comprising omecamtiv mecarbil, processess and uses
Inventor: BI MINGDA
IPC: A61K9/20
Filed: 2014-03-14
Abstract: Omecamtiv mecarbil is a first in class direct activator of cardiac myosin, the motor protein that causes cardiac contraction. It is being evaluated as a potential treatment of heart failure in both intravenous and oral formulations with the goal of establishing a new continuum of care for patients in both the in-hospital and outpatient settings. Clinical trials providing an I.V. delivery of omecamtiv mecarbil have shown that plasma levels of the drug can be delivered safely and effectively. However, standard release formulations and some extended release formulations gave peak to trough ratios that may be too great to provide a safe and effective amount of omecamtiv mecarbil to patients who need the drug in a chronic or preventative setting Accordingly, an effective sustained release formulation would be desirable for increased patient safety and effectiveness. In one aspect, there is provided a pharmaceutical formulation comprising: omecamtiv mecarbil dihydrochloride hydrate; a control release agent; a pH modifying agent selected from the group comprising maleic acid, fumaric acid, tartaric acid, and glutamic acid, and any combination thereof; a filler; and a lubricant.
Patent NZ-731060-A (NZ)
Title: Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists
Inventor: BELANOFF JOSEPH K
IPC: A61K31/513
Filed: 2015-10-14
Abstract: The present invention provides treatment of fatty liver disease using a class of pyrimidinedione cyclohexyl compounds. In one embodiment, the present invention provides a method of treating fatty liver disease. The method includes administering to a subject in need thereof, a therapeutically effective amount of a compound of Formula Id, thereby treating the fatty liver disease, wherein the compound of Formula Id has the structure (Id).